Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations.
暂无分享,去创建一个
H. Muramatsu | K. Fujita | M. Nakao | Yuto Suzuki | Y. Sakai | Hidefumi Sato | Y. Kagawa | Ryota Kurokawa
暂无分享,去创建一个
H. Muramatsu | K. Fujita | M. Nakao | Yuto Suzuki | Y. Sakai | Hidefumi Sato | Y. Kagawa | Ryota Kurokawa